Início › Câncer de Pulmão de Não Pequenas Células › Texas

Ensaios clínicos de Câncer de Pulmão de Não Pequenas Células em Texas

204 estudos para Câncer de Pulmão de Não Pequenas Células estão buscando participantes em locais em Texas.

Cidades em Texas

Texto oficial do estudo (Inglês)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Hendrick Medical Center, Abilene
Houston Methodist San Jacinto Hospital, Baytown
Parkland Memorial Hospital, Dallas
e mais 6

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04267848

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Texas Oncology - DFW ( Site 8103), Dallas
UT Southwestern Medical Center ( Site 0190), Dallas
Houston Methodist Cancer Center ( Site 0191), Houston
e mais 5

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06623422

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

New Experimental Therapeutics - NEXT Oncology, Austin
Texas Oncology, Bedford
UT Southwest Simmons Cancer Center, Dallas
e mais 2

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06465069

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Local Institution - 0095, Houston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07680764

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NEXT Austin, Austin
START Center for Clinical Research, Fort Worth
University of Texas MD Anderson Cancer Center, Houston
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #46, Austin
Exelixis Clinical Site #89, Dallas
Exelixis Clinical Site #73, Irving
e mais 2

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05176483

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

MD Anderson Cancer Center, Houston

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07189871

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center - Conroe, Conroe
University of Texas MD Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston
e mais 3

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07090499

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

SCRI at Mary Crowley, Dallas
University of Texas Southwestern Medical Center, Dallas
The University of Texas MD Anderson Cancer Center, Houston
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06625775

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

MD Anderson Cancer Hospital, Houston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06907615

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Research Site, Tyler

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06996782

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 5, Houston

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07085091

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Texas Oncology - Amarillo Cancer Center, Amarillo
Texas Oncology-Austin Central, Austin
Texas Oncology, Denton
e mais 4

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07361497

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

University Of Texas Medical Branch At Galveston, Galveston
Kelsey-Seybold Clinic Main Campus, Houston
Texas Oncology - San Antonio, San Antonio
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07361510

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

START Fort Worth, Fort Worth
MD Anderson Cancer Center, Houston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07659782

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Houston
Research Site, Round Rock

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05877599

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Joe Arrington Cancer Research /ID# 272776, Lubbock

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06772623

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

NEXT Dallas, Irving

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07578571

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Texas Oncology - South Austin, Austin
Texas Oncology Dallas, Dallas
MD Anderson Cancer Center, Houston
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06881784

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Houston
PHN-012-001 Site, San Antonio

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07127874

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Texas Oncology - West Texas, Abilene
Texas Oncology-Northeast Texas, Allen
Texas Oncology-West Texas, Amarillo
e mais 61

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07144280

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Texas Oncology - West Texas, Abilene
Texas Oncology - Northeast Texas, Allen
Texas Oncology - West Texas, Amarillo
e mais 52

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Oncology Consultants PA, Houston
University of Texas MD Anderson Cancer Center, Houston
US Oncology Research Investigational Products Center, Irving

RecrutandoFase 3

Idades de 18 a 100 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05920356

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Dallas
Research Site, Galveston
Research Site, Houston

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06218914

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

The University of Texas, MD Anderson Cancer Center - Woodlands, Conroe
Renovatio Clinical - El Paso, El Paso
The University of Texas MD Anderson Cancer Center Diagnostic Imaging, Houston
e mais 10

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06758401

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Texas Oncology South, Austin
Parkland Health and Hospital System, Dallas
Texas Oncology DFW, Dallas
e mais 8

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06667076

Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer

UT MD Anderson, Houston

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07579221

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

University of Texas Medical Branch, Galveston
The University of Texas MD Anderson Cancer Center, Houston
Baylor Scott & White Health, Temple

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07154290

Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery

The University of Texas M. D. Anderson Cancer Center, Houston

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06919874

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

MD Anderson Cancer Center, Houston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06667908

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Dallas Cancer Specialists, Garland
Southwest Oncology Associates, Houston
Lumi Research, Houston
e mais 2

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07227298

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Round Rock

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06868277

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

The Center for Cancer and Blood Disorders, Fort Worth
Kelsey-Seybold Clinic, Houston
Houston Methodist Hospital, Houston
e mais 4

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06890598

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Baylor, Scott and White Research Institute, Dallas

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379

Pan-tumor MRD Study

Onocology Consultants P.A. (Oncology Consultants [OC Houston]), Houston
Community Clinical Trials, Kingwood
Christus St. Michael's, Texarkana

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06605404

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Texas Oncology - West Texas, Abilene
University of Texas MD Anderson Cancer Center, Houston
Local Institution - 0517, Houston
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06561386

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Research Site, Fort Worth
Research Site, Houston
Research Site, Kingwood
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06357533

Intratumoral N17350 in Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07339176

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.